Literature DB >> 29069208

Childhood Obesity, MMP-9 Levels, and Vitamin D.

Zeynep Cerit1, Claudio Andrade, Adriana Bosco, Valeria Sandrim, Francisco Silva, Claudio Andrade, Adriana Bosco, Valeria Sandrim, Francisco Silva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29069208      PMCID: PMC5644221          DOI: 10.5935/abc.20170127

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
Dear Editor, I have read the article entitled “MMP-9 Levels and IMT of Carotid Arteries are Elevated in Obese Children and Adolescents Compared to Non-Obese” by Andrade et al.[1], recently published in journal, with great interest. The investigators reported that obese children and adolescents present higher mean intima-media thickness (IMT), plasma matrix metalloproteinase (MMP)-9 and MMP-9/tissue inhibitor of metalloproteinase-1 ratio compared to the non-obese. Thus, these findings indicate that this group presents a risk profile for early atherosclerosis.[1] Childhood obesity is an international public health problem leading to an increased risk of adult obesity and associated with cardiovascular diseases such as hypertension, peripheral and coronary artery disease.[2] Vitamin D (vit D) may regulate adipose tissue mass, differentiation, and metabolism. Vit D deficiency might contribute with overweight and/or obesity, possibly by effects on lipogenesis and/or adipogenesis.[3] Coussens et al.[4] reported an inverse correlation between circulating vit D concentration and serum inflammatory biomarkers. Increased tumor necrosis factor-alpha (TNF-α) is associated with low vit D concentrations. Vit D down-regulates MMP-9 production by TNF-α and decreases production of MMP-9. Wang et al.[5] reported that vit D derivatives could significantly inhibit TNF-α induced MMP-2 and MMP-9 secretion in nasal polyp-derived fibroblasts. In this context, considering a close association among childhood obesity, serum MMP-9 and vit D levels, the correlation of this study’s result[1] with serum vit D levels might be beneficial. We would like to thank you and agree with the considerations inserted in the letter about obesity and atherosclerosis. Indeed, we found a close association between obese children and adolescents with atherosclerosis, compared to non-obese ones.[1] Besides, many authors have cited the important role of Vitamin D in these situations. Certainly, there is an inverse association between Vitamin and obesity. In this point, the Vitamin should regulate the adipose tissue metabolism, although its real role is still unknown, that is, whether it is cause or consequence.[2] Indeed, obesity and Vitamin D deficiency represent an important health concern in the United States among children and adults.[2] Because of the association between cardiovascular risk in obese children and adolescents, Atabeck et al.[3] suggest the prescription of Vitamin D as a way to prevent the premature onset of atherosclerosis. Gul at al.[4] reported that Vitamin D deficiency could contribute with morbidities associated to childhood obesity, such as increasing cardiovascular cardiometabolic risks, atherogenic dyslipidemia and hypertension. In short, we think it would be important to promote more studies in order to prevent and treat atherosclerosis in obesity, as well to considerer the other diseases. Sincerely,
  8 in total

Review 1.  Vitamin D in childhood and adolescence: an expert position statement.

Authors:  Giuseppe Saggese; Francesco Vierucci; Annemieke M Boot; Justyna Czech-Kowalska; Giovanna Weber; Carlos A Camargo; Eric Mallet; Margherita Fanos; Nick J Shaw; Michael F Holick
Journal:  Eur J Pediatr       Date:  2015-04-02       Impact factor: 3.183

2.  Association between vitamin D level and cardiovascular risk in obese children and adolescents.

Authors:  M E Atabek; Beray Selver Eklioglu; Nesibe Akyürek; Hayrullah Alp
Journal:  J Pediatr Endocrinol Metab       Date:  2014-07       Impact factor: 1.634

3.  Prediction of childhood obesity with or without vitamin D deficiency.

Authors:  Zeynep Cerit
Journal:  Eur J Pediatr       Date:  2017-01-24       Impact factor: 3.183

4.  Association between vitamin D levels and cardiovascular risk factors in obese children and adolescents.

Authors:  Ali Gul; Samet Ozer; Resul Yılmaz; Ergun Sonmezgoz; Tuba Kasap; Sahin Takcı; Osman Demir
Journal:  Nutr Hosp       Date:  2017-03-30       Impact factor: 1.057

5.  Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis.

Authors:  Ling-Feng Wang; Chih-Feng Tai; Chen-Yu Chien; Feng-Yu Chiang; Jeff Yi-Fu Chen
Journal:  Kaohsiung J Med Sci       Date:  2015-03-06       Impact factor: 2.744

Review 6.  Vitamin D deficiency & childhood obesity: a tale of two epidemics.

Authors:  Catherine A Peterson; Anthony M Belenchia
Journal:  Mo Med       Date:  2014 Jan-Feb

7.  MMP-9 Levels and IMT of Carotid Arteries are Elevated in Obese Children and Adolescents Compared to Non-Obese.

Authors:  Claudio Andrade; Adriana Bosco; Valeria Sandrim; Francisco Silva
Journal:  Arq Bras Cardiol       Date:  2017-03       Impact factor: 2.000

8.  1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection.

Authors:  Anna Coussens; Peter M Timms; Barbara J Boucher; Timothy R Venton; Anthony T Ashcroft; Keira H Skolimowska; Sandra M Newton; Katalin A Wilkinson; Robert N Davidson; Christopher J Griffiths; Robert J Wilkinson; Adrian R Martineau
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.